Scientific article
English

Economic evaluation of caffeine for apnea of prematurity

Published inPediatrics, vol. 127, no. 1, p. e146-155
Publication date2011
Abstract

To determine the cost-effectiveness of treatment with caffeine compared with placebo for apnea of prematurity in infants with birth weights less than 1250 g, from birth through 18 to 21 months' corrected age.

Keywords
  • Apnea/drug therapy
  • Caffeine/economics/therapeutic use
  • Cost-Benefit Analysis
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature, Diseases/drug therapy
  • Male
  • Retrospective Studies
Citation (ISO format)
DUKHOVNY, Dmitry et al. Economic evaluation of caffeine for apnea of prematurity. In: Pediatrics, 2011, vol. 127, n° 1, p. e146–155. doi: 10.1542/peds.2010-1014
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0031-4005
665views
0downloads

Technical informations

Creation13/12/2012 15:11:00
First validation13/12/2012 15:11:00
Update14/03/2023 19:55:12
Status update14/03/2023 19:55:12
Last indexation30/10/2024 08:19:33
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack